2015
DOI: 10.1159/000441453
|View full text |Cite
|
Sign up to set email alerts
|

Expression and Purification of Recombinant Human Basic Fibroblast Growth Factor Fusion Proteins and Their Uses in Human Stem Cell Culture

Abstract: To reduce the cost of cytokines and growth factors in stem cell research, a simple method for the production of soluble and biological active human basic fibroblast growth factor (hbFGF) fusion protein in Escherichia coli was established. Under optimal conditions, approximately 60-80 mg of >95% pure hbFGF fusion proteins (Trx-6xHis-hbFGF and 6xHis-hbFGF) were obtained from 1 liter of culture broth. The purified hbFGF proteins, both with and without the fusion tags, were biologically active, which was confirmed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…Currently, the commercial bFGF is manufactured in recombinant form mainly in The high expression levels of production of recombinant human bFGF in E. coli is accompanied by problems including misfolding and the formation of insoluble aggregates known as inclusion bodies, which renders the recombinant proteins to be biologically inactive. Addressing this drawback requires extensive and complicated processing (Imsoonthornruksa et al 2015). E. coli system suffers from another di culty which is contamination to endotoxin.…”
Section: Discussionmentioning
confidence: 99%
“…Currently, the commercial bFGF is manufactured in recombinant form mainly in The high expression levels of production of recombinant human bFGF in E. coli is accompanied by problems including misfolding and the formation of insoluble aggregates known as inclusion bodies, which renders the recombinant proteins to be biologically inactive. Addressing this drawback requires extensive and complicated processing (Imsoonthornruksa et al 2015). E. coli system suffers from another di culty which is contamination to endotoxin.…”
Section: Discussionmentioning
confidence: 99%
“…In animal tissues the content of natural bFGF is very limited and its puri cation in quantities that meet the market demand is almost impossible (Gasparian et al, 2009). As a result, during past three decades, considerable efforts have been made for the expression of recombinant bFGF in different organisms including Escherichia coli (Andrades et al, 2001;Gasparian et al, 2009;Jia et al, 2015;Ke et al, 1992;Kwong et al, 2016;Rassouli et al, 2013;Song et al, 2013;Squires et al, 1988;Ping et al 2005;Imsoonthornruksa et al 2015;Soleyman et al 2016), Saccharomyces cerevisiae (Barr et al, 1988), Bacillus subtilis (Kwong et al, 2013), Pichia pastoris (Mu et al, 2008), Bombyx mori L. (silkworm) , rice and soybean (Glycine max) (Ding et al, 2006) seeds, and tobacco (Nicotiana tabacum) chloroplasts (Wang et al, 2015). Currently, the commercial bFGF is manufactured in recombinant form mainly in The high expression levels of production of recombinant human bFGF in E. coli is accompanied by problems including misfolding and the formation of insoluble aggregates known as inclusion bodies, which renders the recombinant proteins to be biologically inactive.…”
Section: Discussionmentioning
confidence: 99%
“…Of these, E. coli is an exemplary choice for the industrial-scale production of hbFGF due to its time-saving and cost-effective nature. Furthermore, various fusion strategies have been employed to enhance the soluble expression of hbFGF, including the utilization of glutathione S-transferase (GST) ( Sheng et al, 2003 ; Sekiguchi et al, 2018 ), thioredoxin (Trx) ( Imsoonthornruksa et al, 2015 ; Soleyman et al, 2016 ), maltose-binding protein (MBP) ( Lemaitre et al, 1995 ), and collagen-like protein (Scl2) ( Rahman et al, 2020 ). Nevertheless, challenges such as insufficient fusion tag cleavage, high costs associated with protease usage, and prolonged processing times have hindered the implementation of these strategies in large-scale production settings.…”
Section: Introductionmentioning
confidence: 99%